Professor Rashida Ferrand
MB BS FRCP MSc PhD DTM&H
I obtained my primary medical degree from the University of Newcastle-upon-Tyne and following postgraduate training in internal medicine and clinical specialist training in HIV Medicine and Sexual Health, I joined the London School of Hygiene and Tropical Medicine to undertake my doctoral training, funded through a Wellcome Trust clinical tropical training fellowship. I am a Wellcome Trust Senior Fellow in Clinical Science.
Since 2007, I have been mainly based in Harare, Zimbabwe where I head a research group conducting clinical and epidemiological studies on HIV infection in adolescents and youth.
In Harare, I am hosted by the Biomedical Research and Training Institute (BRTI). I am an Honorary Consultant Physician in HIV Medicine at Barts Health NHS Trust, London.
I am a tutor on the HIV module for the Distance-based Learning MSc. I currently supervise 4 PhD students as a primary supervisor and am an associate supervisor for a further 3 students. I supervise 2-3 MSc students at LSHTM per annum, as well as post-graduate and post-doctoral students from international academic institutions who are attached to my group through collaborations e.g. from the University of Oxford, University of Tromso, Duke University.
I contribute to undergraduate and postgraduate teaching in public health and clinical medicine at the University of Zimbabwe and teach on research methods courses at the Biomedical Research and Training Institute in Harare. I also support academic activities at the Dept of HIV Medicine at Barts Health NHS Trust.
My research focuses on investigating strategies to improve outcomes across the HIV care cascade.
I am currently leading a cluster randomised trial in Zimbabwe (CHIEDZA trial) of a community-based package of integrated HIV, sexual and reproductive health and general health services for youth aimed at improving HIV outcomes. We are also investigating novel approaches to HIV testing including targeted HIV testing strategies such as index-linked HIV testing incentives, HIV self-testing in tertiary educational institutions and HIV testing of children by their caregivers.
My research group also conducts studies on chronic co-morbidities associated with HIV infection among children and adolescents, particularly HIV-associated lung, cardiac and musculoskeletal disease. I am leading a multi-country RCT of azithromycin for treatment of HIV-associated chronic lung disease.
We collaborate with the University of Oxford, the Univerity of Cape Town and the University of Tromso, on studies to investigate the immunogenetic correlates of slow progression of HIV infection in children and the pathogenesis of chronic complications.